Viz.ai and IMVARIA Partner to Expand AI Capabilities for Interstitial Lung Disease
SAN FRANCISCO — November 18, 2025 — Viz.ai, the leader in AI-powered disease detection and care coordination, today announced a...
Nov 18, 2025
All Resources
Explore our latest resources
Viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients
New software will incorporate natural language processing (NLP) for more effective patient screening and follow-up SAN FRANCISCO – October 21,...
Oct 21, 2024
Viz.ai Wins 2024 Edison Award™ for Innovation for Second Year in a Row
Honored for excellence in innovation in cardiovascular & ophthalmic innovations SAN FRANCISCO – April 19, 2024 – Viz.ai, the leader...
Apr 19, 2024
Viz.ai and iCardio.ai Partner on Aortic Stenosis Detection Using Ultrasound Imaging and Artificial...
Aims to accelerate aortic stenosis detection, reduce health disparities, and improve patient outcomes Viz.ai, the leader in AI-powered disease detection...
Apr 02, 2024
New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism
Company’s artificial intelligence technology shows 74% reduction in in-hospital mortality rates for pulmonary embolism SAN FRANCISCO – March 7, 2024...
Mar 07, 2024
New Clinical Data Supports Viz.ai Solution for Improved Pulmonary Embolism Detection and Care...
Company’s Artificial Intelligence Technology Shows Better Results in Early Detection and Patient Care SAN FRANCISCO, CA – September 21 –...
Sep 21, 2023